PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50122C00073Overall objective of THIS contract IS — Biofire Defense LLC

Biofire Defense LLC holds $41.2M across 235 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Dec 22, 2027 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma
Awarding office
Biofire Defense LLC
Recipient
Dec 22, 2027
PoP end
$16M
Obligated
$16M
Potential
541714
NAICS
AN13
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Biofire Defense LLC — $90

Contract facts

NONE
Contract number75A50122C00073
AgencyBarda - Aspr / Daappo / Barda Dcma
Awarding officeBarda - Aspr / Daappo / Barda Dcma
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentBiofire Defense LLC
CAGE088J2
UEINHMDGM122546
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN13
Place of performanceSALT LAKE CITY UT
Pricing typeCost Plus Fixed Fee
Extent competedFull And Open Competition
Related solicitationBAA-18-100-SOL-00003
PoP startSep 30, 2022
PoP end (current)Dec 22, 2027
Obligated$16M
Current value$16M
Potential value$16M

THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF THE BIOFIRE EMERGING COV PANEL AS A NUCLEIC ACID AMPLIFICATION TEST PANEL FOR USE ON THE EASY-TO-USE FILMARRAY 2.0 AND FILMARRAY TORCH PLATFORMS. is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Biofire Defense LLC. Estimated value $16M ($16M obligated). Current period of performance ends Dec 22, 2027. Last award drew 1 bidder. Place of performance: SALT LAKE CITY UT. Related solicitation BAA-18-100-SOL-00003.

THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF THE BIOFIRE EMERGING COV PANEL AS A NUCLEIC ACID AMPLIFICATION TEST PANEL FOR USE ON THE EASY-TO-USE FILMARRAY 2.0 AND FILMARRAY TORCH PLATFORMS.

Recompete timing

Public
Expiring in 488 days

Current PoP ends Dec 22, 2027 (488 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Jun 22, 2026.

Incumbent footprint

Public record

Biofire Defense LLC$41.2M obligated across 235 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($41.2M) · all agencies
Department of Health and Human Services (HHS)$23.8M · 58%Department of Defense (DOD)$14.4M · 35%Department of State (DOS)$2.8M · 7%General Services Administration (GSA)$104K · 0%
Open full company profile

Related awards

Same incumbent
N3239825FA005
RESPIRATORY PANELS
$313K
Sep 15, 2026
W81K0225FA133
EQUIPMENT LEASE CONTRACT FOR TWO MULTIPLEX MOLECULAR ANALYZER SYSTEMS AND THE SUPPLY OF TE…
$968K
Sep 30, 2026
W911SR26FA022
THE CONTRACTOR SHALL CONDUCT AN ENGINEERING STUDY TO DEFINE A RAPID DIAGNOSTIC DEVELOPMENT…
$272K
Oct 13, 2026
75A50122C00057
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF THE REVEAL RAPID A…
$12.4M
Dec 31, 2026
19AQMM24P0173
EXTENDED PRODUCT WARRANTY FOR THE FILMARRAY EQUIPMENT.
$262K
Jan 20, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75A50122C00073?

75A50122C00073 (Overall objective of THIS contract IS) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $16M, currently held by Biofire Defense LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50122C00073?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50122C00073 to Biofire Defense LLC (potential $16M).

Who is the incumbent on 75A50122C00073?

Biofire Defense LLC is the incumbent with $41.2M across 235 related awards in SCOUT’s public footprint. The current period of performance ends Dec 22, 2027.

When does Biofire Defense LLC’s 75A50122C00073 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 22, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50122C00073